Search research articles
Contact Us
Filters
Showing results (121-130 of 175) with videos related to
Page
of 18
Sort By:
Plos One
|
November 22, 2019
Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European survey
Andrea De Luca, Patrizio Pezzotti, Charles Boucher, et al.
The Journal of Infection
|
March 11, 2023
Hepatitis B virus infection in general practice across England: An analysis of the Royal College of General Practitioners Research and Surveillance Centre real-world database
Anna Maria Geretti, Harrison Austin, Giovanni Villa, et al.
Virology Journal
|
February 10, 2025
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study)
Collins Iwuji, Laura Waters, Ana Milinkovic, et al.
The Journal of Antimicrobial Chemotherapy
|
August 28, 2015
Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades
Tomas Doyle, David T Dunn, Francesca Ceccherini-Silberstein, et al.
Hepatology (Baltimore, Md.)
|
March 2, 2011
Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection
Anna Schurich, Pooja Khanna, A Ross Lopes, et al.
Scientific Reports
|
April 9, 2024
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection
Ludovica Ferrari, Alessandra Ruggiero, Chiara Stefani, et al.
AIDS Reviews
|
April 10, 2018
State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap
Charles A Boucher, Marina R Bobkova, Anna Maria Geretti, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 25, 2018
HIV gp120 in the Lungs of Antiretroviral Therapy-treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci
Paul J Collini, Martin A Bewley, Mohamed Mohasin, et al.
HIV Medicine
|
August 30, 2016
British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015
Anna Maria Geretti, Gary Brook, Claire Cameron, et al.
BMJ (Clinical Research Ed.)
|
November 22, 2005
Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study
Patricia Cane, Ian Chrystie, David Dunn, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 175) with videos related to
Sort By:
Page
of 18
Plos One
|
November 22, 2019
Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European survey
Andrea De Luca, Patrizio Pezzotti, Charles Boucher, et al.
The Journal of Infection
|
March 11, 2023
Hepatitis B virus infection in general practice across England: An analysis of the Royal College of General Practitioners Research and Surveillance Centre real-world database
Anna Maria Geretti, Harrison Austin, Giovanni Villa, et al.
Virology Journal
|
February 10, 2025
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study)
Collins Iwuji, Laura Waters, Ana Milinkovic, et al.
The Journal of Antimicrobial Chemotherapy
|
August 28, 2015
Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades
Tomas Doyle, David T Dunn, Francesca Ceccherini-Silberstein, et al.
Hepatology (Baltimore, Md.)
|
March 2, 2011
Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection
Anna Schurich, Pooja Khanna, A Ross Lopes, et al.
Scientific Reports
|
April 9, 2024
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection
Ludovica Ferrari, Alessandra Ruggiero, Chiara Stefani, et al.
AIDS Reviews
|
April 10, 2018
State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap
Charles A Boucher, Marina R Bobkova, Anna Maria Geretti, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 25, 2018
HIV gp120 in the Lungs of Antiretroviral Therapy-treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci
Paul J Collini, Martin A Bewley, Mohamed Mohasin, et al.
HIV Medicine
|
August 30, 2016
British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015
Anna Maria Geretti, Gary Brook, Claire Cameron, et al.
BMJ (Clinical Research Ed.)
|
November 22, 2005
Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study
Patricia Cane, Ian Chrystie, David Dunn, et al.
Page
of 18